David Bierge Valero

Prevalence and characterization of heart failure in Aragon, Spain (ICAR study)

Juan Carlos Romero-Vigara, Jose Ignacio González Lillo, David Bierge Valero, Patricia Arbués-Espinosa et autres

Introduction: Heart failure (HF) imposes a significant clinical and care burden. The ICAR study sought to address the absence of recent population estimates and an integrated approach to the diagnosis of HF in Spain, specifically in the region of Aragon. Methods: Population-based, …

es, qa, vn (code pays fourni par la source)

Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry

Guillaume Roger, Grégory Ducrocq, Jules Mesnier, Neila Sayah et autres

BACKGROUND AND AIMS: It has been reported that patients without standard modifiable cardiovascular (CV) risk factors (SMuRFs-diabetes, dyslipidaemia, hypertension, and smoking) presenting with first myocardial infarction (MI), especially women, have a higher in-hospital mortality than patients with risk factors, and possibly a …

fr, it, gb, ca, pl (code pays fourni par la source)

Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry

Giuseppe Ambrosio, M.G. Crespo Leiro, Lars H. Lund, Stefano Coiro et autres

it, es, se, cy, de, fr, ee (code pays fourni par la source)

Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

Marco Canepa, Cândida Fonseca, Cécile Laroche, María G. Crespo‐Leiro et autres

it, pt, fr, ro, es (code pays fourni par la source)